117 related articles for article (PubMed ID: 35687133)
1. TBX2 acts as a potent transcriptional silencer of tumour suppressor genes through interaction with the CoREST complex to sustain the proliferation of breast cancers.
McIntyre AJ; Angel CZ; Smith JS; Templeman A; Beattie K; Beattie S; Ormrod A; Devlin E; McGreevy C; Bothwell C; Eddie SL; Buckley NE; Williams R; Mullan PB
Nucleic Acids Res; 2022 Jun; 50(11):6154-6173. PubMed ID: 35687133
[TBL] [Abstract][Full Text] [Related]
2. TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells.
Crawford NT; McIntyre AJ; McCormick A; D'Costa ZC; Buckley NE; Mullan PB
Oncogene; 2019 Aug; 38(31):5971-5986. PubMed ID: 31253870
[TBL] [Abstract][Full Text] [Related]
3. T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells.
Redmond KL; Crawford NT; Farmer H; D'Costa ZC; O'Brien GJ; Buckley NE; Kennedy RD; Johnston PG; Harkin DP; Mullan PB
Oncogene; 2010 Jun; 29(22):3252-62. PubMed ID: 20348948
[TBL] [Abstract][Full Text] [Related]
4. TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
D'Costa ZC; Higgins C; Ong CW; Irwin GW; Boyle D; McArt DG; McCloskey K; Buckley NE; Crawford NT; Thiagarajan L; Murray JT; Kennedy RD; Mulligan KA; Harkin DP; Waugh DJ; Scott CJ; Salto-Tellez M; Williams R; Mullan PB
Oncotarget; 2014 Mar; 5(6):1609-20. PubMed ID: 24742492
[TBL] [Abstract][Full Text] [Related]
5. Physical and functional interaction between PML and TBX2 in the establishment of cellular senescence.
Martin N; Benhamed M; Nacerddine K; Demarque MD; van Lohuizen M; Dejean A; Bischof O
EMBO J; 2012 Jan; 31(1):95-109. PubMed ID: 22002537
[TBL] [Abstract][Full Text] [Related]
6. The T box transcription factor TBX2 promotes epithelial-mesenchymal transition and invasion of normal and malignant breast epithelial cells.
Wang B; Lindley LE; Fernandez-Vega V; Rieger ME; Sims AH; Briegel KJ
PLoS One; 2012; 7(7):e41355. PubMed ID: 22844464
[TBL] [Abstract][Full Text] [Related]
7. LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene.
Ambrosio S; Amente S; Saccà CD; Capasso M; Calogero RA; Lania L; Majello B
Oncotarget; 2017 Jan; 8(3):3854-3869. PubMed ID: 27894074
[TBL] [Abstract][Full Text] [Related]
8. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.
Jacobs JJ; Keblusek P; Robanus-Maandag E; Kristel P; Lingbeek M; Nederlof PM; van Welsem T; van de Vijver MJ; Koh EY; Daley GQ; van Lohuizen M
Nat Genet; 2000 Nov; 26(3):291-9. PubMed ID: 11062467
[TBL] [Abstract][Full Text] [Related]
9. UV-mediated regulation of the anti-senescence factor Tbx2.
Abrahams A; Mowla S; Parker MI; Goding CR; Prince S
J Biol Chem; 2008 Jan; 283(4):2223-30. PubMed ID: 18025091
[TBL] [Abstract][Full Text] [Related]
10. Endocrine resistance and breast cancer plasticity are controlled by CoREST.
Garcia-Martinez L; Adams AM; Chan HL; Nakata Y; Weich N; Stransky S; Zhang Z; Alshalalfa M; Sarria L; Mahal BA; Kesmodel SB; Celià-Terrassa T; Liu Z; Minucci S; Bilbao D; Sidoli S; Verdun RE; Morey L
Nat Struct Mol Biol; 2022 Nov; 29(11):1122-1135. PubMed ID: 36344844
[TBL] [Abstract][Full Text] [Related]
11. Combined genomic and proteomic approaches reveal DNA binding sites and interaction partners of TBX2 in the developing lung.
Lüdtke TH; Wojahn I; Kleppa MJ; Schierstaedt J; Christoffels VM; Künzler P; Kispert A
Respir Res; 2021 Mar; 22(1):85. PubMed ID: 33731112
[TBL] [Abstract][Full Text] [Related]
12. ZNF516 suppresses EGFR by targeting the CtBP/LSD1/CoREST complex to chromatin.
Li L; Liu X; He L; Yang J; Pei F; Li W; Liu S; Chen Z; Xie G; Xu B; Ting X; Zhang Z; Jin T; Liu X; Zhang W; Yuan S; Yang Z; Wu C; Zhang Y; Yang X; Yi X; Liang J; Shang Y; Sun L
Nat Commun; 2017 Sep; 8(1):691. PubMed ID: 28947780
[TBL] [Abstract][Full Text] [Related]
13. T-box genes coordinate regional rates of proliferation and regional specification during cardiogenesis.
Cai CL; Zhou W; Yang L; Bu L; Qyang Y; Zhang X; Li X; Rosenfeld MG; Chen J; Evans S
Development; 2005 May; 132(10):2475-87. PubMed ID: 15843407
[TBL] [Abstract][Full Text] [Related]
14. Microphthalmia-associated transcription factor/T-box factor-2 axis acts through Cyclin D1 to regulate melanocyte proliferation.
Pan L; Ma X; Wen B; Su Z; Zheng X; Liu Y; Li H; Chen Y; Wang J; Lu F; Qu J; Hou L
Cell Prolif; 2015 Dec; 48(6):631-42. PubMed ID: 26486273
[TBL] [Abstract][Full Text] [Related]
15. Genome analysis identifies the p15ink4b tumor suppressor as a direct target of the ZNF217/CoREST complex.
Thillainadesan G; Isovic M; Loney E; Andrews J; Tini M; Torchia J
Mol Cell Biol; 2008 Oct; 28(19):6066-77. PubMed ID: 18625718
[TBL] [Abstract][Full Text] [Related]
16. Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas.
Vance KW; Carreira S; Brosch G; Goding CR
Cancer Res; 2005 Mar; 65(6):2260-8. PubMed ID: 15781639
[TBL] [Abstract][Full Text] [Related]
17. The anti-proliferative function of the TGF-β1 signaling pathway involves the repression of the oncogenic TBX2 by its homologue TBX3.
Li J; Ballim D; Rodriguez M; Cui R; Goding CR; Teng H; Prince S
J Biol Chem; 2014 Dec; 289(51):35633-43. PubMed ID: 25371204
[TBL] [Abstract][Full Text] [Related]
18. TBX2 blocks myogenesis and promotes proliferation in rhabdomyosarcoma cells.
Zhu B; Zhang M; Byrum SD; Tackett AJ; Davie JK
Int J Cancer; 2014 Aug; 135(4):785-97. PubMed ID: 24470334
[TBL] [Abstract][Full Text] [Related]
19. A novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance.
Wansleben S; Davis E; Peres J; Prince S
Cell Death Dis; 2013 Oct; 4(10):e846. PubMed ID: 24113180
[TBL] [Abstract][Full Text] [Related]
20. Murine Tbx2 contains domains that activate and repress gene transcription.
Paxton C; Zhao H; Chin Y; Langner K; Reecy J
Gene; 2002 Jan; 283(1-2):117-24. PubMed ID: 11867218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
